Advances in the Assessment of No-Reflow After Successful Primary Percutaneous Coronary Intervention for Acute ST-Segment Elevation Myocardial Infarction. Now That We Can Diagnose It, What Do We Do About It?**Editorials published in the Journal of the American College of Cardiology reflect the views of the authors

Journal of the American College of Cardiology

Volumn 51, Issue 5, 2008, Pages 566-568

  Grayburn, Paul A ^a   Choi, James W ^a  

^a BAYLOR UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CORONARY ARTERY BLOOD FLOW; EDITORIAL; HEART ATRIUM FIBRILLATION; HEART INFARCTION; HUMAN; MICROCIRCULATION; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; ST SEGMENT;

ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; CORONARY CIRCULATION; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAPHY; HUMANS; MICROCIRCULATION; MYOCARDIAL INFARCTION; VASCULAR RESISTANCE; VENTRICULAR REMODELING;

EID: 38649096646     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jacc.2007.10.024     Document Type: Editorial

References (22)

1. Kloner R.A., Ganote C.E., and Jennings R.B. The 'no-reflow' phenomenon after temporary coronary occlusion in the dog. J Clin Invest 54 (1974) 1496-1508
2. Ito H., Tomooka T., and Sakai N. Lack of myocardial perfusion immediately after successful thrombolysis: a predictor of poor recovery of left ventricular function in anterior myocardial infarction. Circulation 85 (1992) 1699-1705
3. Ito H., Maruyama A., Iwakura K., et al. Clinical implications of the 'no reflow' phenomenon. A predictor of complications and left ventricular remodeling in reperfused anterior wall myocardial infarction. Circulation 93 (1996) 223-228
4. Morishima I., Sone T., Okumura K., et al. Angiographic no-reflow phenomenon as a predictor of adverse long-term outcome in patients treated with percutaneous transluminal coronary angioplasty for first acute myocardial infarction. J Am Coll Cardiol 36 (2000) 1202-1209
5. Antman E.M., Anbe D.T., Armstrong P.W., et al. ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction: executive summary: a report of the ACC/AHA Task Force on Practice Guidelines (Committee to Revise the 1999 Guidelines on the Management of Patients With Acute Myocardial Infarction). J Am Coll Cardiol 44 (2004) 671-719
6. Fearon W.F., Shah M., Ng M., et al. Predictive value of the index of microcirculatory resistance in patients with ST-segment elevation myocardial infarction. J Am Coll Cardiol 51 (2008) 560-565
7. Galiuto L., Garramone B., Scara A., et al., AMICI Investigators. The extent of microvascular damage at myocardial contrast echocardiography is superior to other known indexes of post-infarct reperfusion in predicting left ventricular remodeling: results of the AMICI study. J Am Coll Cardiol 51 (2008) 552-559
8. Choi J.W., Gibson C.M., Murphy S.A., Davidson C.J., Kim R.J., and Ricciardi M.J. Myonecrosis following stent placement: association between impaired TIMI myocardial perfusion grade (TMPG) and MRI visualization of microinfarction. Cathet Cardiovasc Intervent 61 (2004) 472-476
9. Kaul S. Evaluating the 'no reflow' phenomenon with myocardial contrast echocardiography. Basic Res Cardiol 101 (2006) 391-399
10. Wei K., Jayaweera A.R., Firoozan S., Linka A., Skyba D.M., and Kaul S. Quantification of myocardial blood flow with ultrasound-induced destruction of microbubbles administered as a constant venous infusion. Circulation 97 (1998) 473-483
11. Stone G.W., Webb J., Cox D.A., et al. Distal microcirculatory protection during percutaneous coronary intervention in acute ST-segment elevation myocardial infarction: a randomized controlled trial. JAMA 293 (2005) 1063-1072
12. Stone G.W., Grines C.L., Cox D.A., et al. Comparison of angioplasty with stenting, with or without abciximab, in acute myocardial infarction. N Engl J Med 346 (2002) 957-966
13. Montalescot G., Barragan P., Wittenberg O., et al. Platelet glycoprotein IIb/IIIa inhibition with coronary stenting for acute myocardial infarction. N Engl J Med 344 (2001) 1895-1903
14. Taniyama Y., Ito H., Iwakura K., et al. Beneficial effect of intracoronary verapamil on microvascular and myocardial salvage in patients with acute myocardial infarction. J Am Coll Cardiol 30 (1997) 1193-1199
15. Umemura S., Nakamura S., Sugiura T., et al. The effect of verapamil on the restoration of myocardial perfusion and functional recovery in patients with angiographic no-reflow after primary percutaneous coronary intervention. Nucl Med Commun 27 (2006) 247-254
16. Huang R.I., Patel P., Walinsky P., et al. Efficacy of intracoronary nicardipine in the treatment of no-reflow during percutaneous coronary intervention. Catheter Cardiovasc Interv 68 (2006) 671-676
17. Pasceri V., Pristipino C., Pelliccia F., et al. Effects of the nitric oxide donor nitroprusside on no-reflow phenomenon during coronary interventions for acute myocardial infarction. Am J Cardiol 95 (2005) 1358-1361
18. AMISTAD-II Investigators. A randomized, double-blinded, placebo-controlled multicenter trial of adenosine as an adjunct to reperfusion in the treatment of acute myocardial infarction (AMISTAD-II). J Am Coll Cardiol 45 (2005) 1775-1780
19. Ito H., Taniyama Y., Iwakura K., et al. Intravenous nicorandil can preserve microvascular integrity and myocardial viability in patients with reperfused anterior wall myocardial infarction. J Am Coll Cardiol 33 (1999) 654-660
20. Ishii H., Ichimiya S., Kanashiro M., et al. Impact of a single intravenous administration of nicorandil before reperfusion in patients with ST-segment elevation myocardial infarction. Circulation 112 (2005) 1284-1288
21. Theroux P., Chaitman B.R., Danchin N., et al. Inhibition of the sodium-hydrogen exchanger with cariporide to prevent myocardial infarction in high-risk ischemic situations. Main results of the GUARDIAN trial. Guard during ischemia against necrosis (GUARDIAN) Investigators. Circulation 102 (2000) 3032-3038
22. Zeymer U., Opolski G., Davies J., et al. The Na+/H+ exchange inhibitor eniporide as an adjunct to early reperfusion therapy for acute myocardial infarction. Results of the evaluation of the safety and cardioprotective effects of eniporide in acute myocardial infarction (ESCAMI) trial. J Am Coll Cardiol 38 (2001) 1644-1650